Hält derzeit Positionen bei Aclaris Therapeutics Inc and Idera Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Director | Aclaris Therapeutics Inc | 7. Januar 2020 - |
President, Chief Executive Officer, Director | Idera Pharmaceuticals Inc | 1. Dezember 2014 - |
Independent Director | Spark Therapeutics Inc | 1. Juni 2014 - 17. Dezember 2019 |
Independent Director | Vanda Pharmaceuticals Inc | 21. April 2010 - 1. Juni 2019 |
Chairman of the Board, President, Chief Executive Officer | Shire Viropharma Inc | 31. Dezember 2008 - 24. Januar 2014 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2021-11-24 | 2021-11-24 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
K Kauf |
7.500
+75.0%
12,1991.425 USD |
7.500 +75.0% | 12,19 | 91.425 USD | |
2021-01-12 | 2021-01-12 |
Idera Pharmaceuticals Inc
(IDRA)
|
V Verkauf |
3.210
-1.5%
4,2013.474 USD |
3.210 -1.5% | 4,20 | 13.474 USD | |
2021-01-11 | 2021-01-05 |
Idera Pharmaceuticals Inc
(IDRA)
|
V Verkauf |
2.740
-1.3%
3,9110.700 USD |
2.740 -1.3% | 3,91 | 10.700 USD | |
2020-12-22 | 2020-12-22 |
Idera Pharmaceuticals Inc
(IDRA)
|
GV Geplanter Verkauf |
37.169
-14.8%
4,32160.525 USD |
37.169 -14.8% | 4,32 | 160.525 USD | |
2020-01-10 | 2020-01-07 |
Idera Pharmaceuticals Inc
(IDRA)
|
V Verkauf |
3.006
-3.4%
1,785.352 USD |
3.006 -3.4% | 1,78 | 5.352 USD |